首页> 美国卫生研究院文献>Antibodies >Targeting Dendritic Cells with Antigen-Delivering Antibodies for Amelioration of Autoimmunity in Animal Models of Multiple Sclerosis and Other Autoimmune Diseases
【2h】

Targeting Dendritic Cells with Antigen-Delivering Antibodies for Amelioration of Autoimmunity in Animal Models of Multiple Sclerosis and Other Autoimmune Diseases

机译:靶向树突状细胞与抗原传递抗体的多发性硬化症和其他自身免疫性疾病动物模型中改善自身免疫性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The specific targeting of dendritic cells (DCs) using antigen-delivering antibodies has been established to be a highly efficient protocol for the induction of tolerance and protection from autoimmune processes in experimental autoimmune encephalomyelitis (EAE), a model of multiple sclerosis (MS), as well as in some other animal disease models. As the specific mechanisms of such induced tolerance are being investigated, the newly gained insights may also possibly help to design effective treatments for patients. Here we review approaches applied for the amelioration of autoimmunity in animal models based on antibody-mediated targeting of self-antigens to DCs. Further, we discuss relevant mechanisms of immunological tolerance that underlie such approaches, and we also offer some future perspectives for the application of similar methods in certain related disease settings such as transplantation.
机译:已经建立了使用抗原递送抗体特异性靶向树突状细胞(DC)的方法,是诱导实验性自身免疫性脑脊髓炎(EAE),多发性硬化症(MS)模型,以及其他一些动物疾病模型。由于正在研究这种诱导耐受性的具体机制,因此,新获得的见解也可能有助于设计针对患者的有效治疗方法。在这里,我们回顾了基于抗体介导的针对DC的自身抗原靶向,在动物模型中改善自身免疫的方法。此外,我们讨论了构成此类方法基础的免疫耐受的相关机制,并且还提供了在某些相关疾病(例如移植)中应用类似方法的未来前景。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号